Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
Contact
  • Home
  • /
  • Insights
  • /
  • Restriction Spectrum Imaging (RSI) improves cancer detection

Restriction Spectrum Imaging (RSI) improves cancer detection

Compares the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. 2016.

[button]Download[/button]

  • Topic: Published research

Insights

Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
  • 3 mins

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.

,

Cortechs.ai | Cortechs.ai Partners with Mermaid Beach Radiology to Bring Precision AI Imaging Solutions to Their MRI and CT Services
  • 2 mins

01/09/2025

Cortechs.ai Partners with Mermaid Beach Radiology to Bring Precision AI Imaging Solutions to Their MRI and CT Services

This collaboration marks a leap forward in delivering innovative, data-driven care and reflects our excitement to expand our reach globally.

,

Cortechs.ai | Elevating Neurological CT Precision and Efficiency
  • 2 mins

12/19/2024

Elevating Neurological CT Precision and Efficiency

Learn how this powerful tool improves measurement accuracy, clinical confidence, and patient outcomes by streamlining workflows.

View our insights
Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

  • Solutions
  • © Cortechs.ai 2024
Scroll to Top